Tytgat GN - Search Results

1

Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials.

Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, Peterson TC, Nyrén O, Bradley LA, Verlinden M, Tytgat GN. Veldhuyzen van Zanten SJ, et al. Among authors: tytgat gn. Am J Gastroenterol. 1996 Apr;91(4):660-73. Am J Gastroenterol. 1996. PMID: 8677926

2

Prognostic factors for relapse and maintenance treatment with cisapride in gastro-oesophageal reflux disease.

Tytgat GN, Blum AL, Verlinden M. Tytgat GN, et al. Aliment Pharmacol Ther. 1995 Jun;9(3):271-80. doi: 10.1111/j.1365-2036.1995.tb00381.x. Aliment Pharmacol Ther. 1995. PMID: 7654889 Clinical Trial.

3

Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index.

Talley NJ, Haque M, Wyeth JW, Stace NH, Tytgat GN, Stanghellini V, Holtmann G, Verlinden M, Jones M. Talley NJ, et al. Among authors: tytgat gn. Aliment Pharmacol Ther. 1999 Feb;13(2):225-35. doi: 10.1046/j.1365-2036.1999.00445.x. Aliment Pharmacol Ther. 1999. PMID: 10102954 Free article.

4

Decision-making in dyspepsia: controversies in primary and secondary care.

Tytgat G, Hungin AP, Malfertheiner P, Talley N, Hongo M, McColl K, Soule JC, Agréus L, Bianchi-Porro G, Freston J, Hunt R. Tytgat G, et al. Eur J Gastroenterol Hepatol. 1999 Mar;11(3):223-30. doi: 10.1097/00042737-199903000-00003. Eur J Gastroenterol Hepatol. 1999. PMID: 10333192 Review. No abstract available.

5

Functional gastroduodenal disorders.

Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Talley NJ, et al. Among authors: tytgat gn. Gut. 1999 Sep;45 Suppl 2(Suppl 2):II37-42. doi: 10.1136/gut.45.2008.ii37. Gut. 1999. PMID: 10457043 Free PMC article. Review.

6

Therapeutic options after failed Helicobacter pylori eradication therapy.

van der Hulst RW, Weel JF, van der Ende A, ten Kate FJ, Dankert J, Tytgat GN. van der Hulst RW, et al. Among authors: tytgat gn. Am J Gastroenterol. 1996 Nov;91(11):2333-7. Am J Gastroenterol. 1996. PMID: 8931413 Clinical Trial.

7

Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study.

Van der Hulst RW, Rauws EA, Köycü B, Keller JJ, Bruno MJ, Tijssen JG, Tytgat GN. Van der Hulst RW, et al. Among authors: tytgat gn. Gastroenterology. 1997 Oct;113(4):1082-6. doi: 10.1053/gast.1997.v113.pm9322501. Gastroenterology. 1997. PMID: 9322501

8

Is gastroduodenitis a cause of chronic dyspepsia?

Tytgat GN, Noach LA, Rauws EA. Tytgat GN, et al. Scand J Gastroenterol Suppl. 1991;182:33-9. doi: 10.3109/00365529109109535. Scand J Gastroenterol Suppl. 1991. PMID: 1896828 Review.

9

Lack of accuracy of the noninvasive Helicobacter pylori stool antigen test in patients with gastroduodenal ulcer bleeding.

van Leerdam ME, van der Ende A, ten Kate FJ, Rauws EA, Tytgat GN. van Leerdam ME, et al. Among authors: tytgat gn. Am J Gastroenterol. 2003 Apr;98(4):798-801. doi: 10.1111/j.1572-0241.2003.07387.x. Am J Gastroenterol. 2003. PMID: 12738458

10

Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon.

Mathus-Vliegen EM, Tytgat GN, Veldhuyzen-Offermans EA. Mathus-Vliegen EM, et al. Among authors: tytgat gn. Gastroenterology. 1990 Aug;99(2):362-9. doi: 10.1016/0016-5085(90)91017-z. Gastroenterology. 1990. PMID: 2194894 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

875 results

Search Page